drugset / Trial / NCT06389682
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients
NaSingle-groupOpen-labelDiagnostic
Summary
68Ga-NYM005 is a CAIX-targeting small-molecular radiotracer for PET/CT imaging of clear cell renal cell carcinoma
Timeline
- Start
- 2024-06-17
- Primary completion
- 2025-01-08
- Completion
- 2025-01-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-NYM005 | Diagnostic / imaging agent | 74 mbq | Intravenous |
| Subject | 68Ga-NYM005 | Diagnostic / imaging agent | 259 mbq | Intravenous |